FDA will hold a public meeting March 27 to gather input on efforts to reform its data strategy, which the agency laid out in its Technology Modernization Action Plan (T-MAP) in September. FDA wants to discuss the consequences of moving from “static point-in-time data sets” to data that are shared and updated digitally, including possible data duplication, as well as potential data standards and data privacy issues, according to a Tuesday (Jan. 7) meeting announcement. FDA also wants to tackle...